Proactive Investors
09 Jun 2026, 09:17 UTC · 2h ago
Thor Energy lifted by hydrogen project update
Proactive Investors
09 Jun 2026, 09:17 UTC · 2h ago
Story key points
3 claims · impact-rated
Thor Energy PLC recorded natural hydrogen readings of up to 3% (30,000 ppm) during Phase-2 survey work at its HY-Range project. — Significantly high readings (60,000x background levels) increase the probability of a commercial discovery, directly driving the 25% share price increase.
+0.60Imaging Biometrics Ltd reported positive Phase 1 results for its oral gallium maltolate treatment in recurrent glioblastoma, noting it was safe and well-tolerated. — Successful Phase 1 safety data is a critical milestone for biotech assets, though the small sample size limits immediate impact.
+0.40Thor Energy plans to announce a 2D seismic acquisition programme to define definitive drilling targets at the Lochiel and Crystal focus areas. — The transition from surface surveys to seismic work represents a tangible move toward drilling, increasing the project's maturity.
+0.30Ticker attribution
Continue reading
6 related stories
Top 2 movers · tap to explore
Model heads
Shares rose 25% following survey results that far exceeded expectations for natural hydrogen readings.
Published positive Phase 1 results showing its treatment for glioblastoma was safe and well-tolerated.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
4 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Proactive Investors
5h ago
